|
|
||||||||
RESEARCH REPORT |
1 Department of Preventive and Restorative Dental Sciences, University of California, 707 Parnassus Avenue, D-2260, San Francisco, CA 94143-0758, USA; and
2 Department of Growth and Development, University of California, 533 Parnassus Avenue, San Francisco, CA 94143, USA;
* corresponding author, shabeli{at}itsa.ucsf.edu
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: enamel amelogenin biomimetics apatite atomic force microscopy
| INTRODUCTION |
|---|
|
|
|---|
In vitro studies on seeded apatite crystals with the use of extracted or recombinant amelogenin resulted in protein adsorption and altered crystal morphology (Doi et al., 1984; Moradian-Oldak et al., 1998). Wen et al. (1999a, 2000) introduced mineralization studies on bioactive glasses using amelogenin. The presence of up to 50 µg/mL recombinant murine amelogenin during crystallization resulted in the formation of bundles of elongated apatite crystals. Hunter et al.(1999), however, using up to 30 µg/mL recombinant amelogenin, did not observe significant effects in the de novo formation of hydroxyapatite.
The ionic environment in which enamel matures appears to be controlled by ameloblasts regulating predominantly the calcium concentration to unusually low levels (Aoba and Moreno, 1987). It is therefore speculated that physical-chemical conditions, e.g., saturation, may affect the ability of mineralizing enamel matrix proteins to interact with inorganic phases. Amelogenin proteins are secreted in high quantities and most likely precipitate in the enamel matrix, since the limit of solubility is only 0.7 mg/mL at physiological pH (Tan et al., 1998). Amelogenin self-assembly into nanospheres and the ability to guide octacalcium phosphate crystal growth are dose-dependent (Wen et al., 2001). This study tested whether amelogenin protein interactions with the forming apatite mineral were affected by protein concentrations above the solubility limit and determined if protein-controlled mineralization on apatite templates is dependent on the crystallographic orientation of the template.
| MATERIALS & METHODS |
|---|
|
|
|---|
|
Crystal Growth Experiments
All solutions were vortexed before use. We performed the experiments by placing a FAP substrate into a 1.5-mL siliconized test-tube and adding each compound of corresponding solutions to a total volume of 400 µL. The final concentrations of the solutions were: (1) protein only, rH174 at 0.4 and 1.6 mg/mL in 50 mM Tris/HCl; (2) buffered mineralizing solution (CaP-sol) containing 0.5, 2.5, and 150 mM Ca2+, PO43-, and Tris, respectively; and (3) rH174 at 0.4 or 1.6 mg/mL with CaP-sol. For experiments #2 and #3, solutions were added in the following sequence: (1) 50 µL of eight-fold Ca2+ solution, (2) 300 µL of 0.1% TFA (#2) or 2.2 mg/mL rH174 stock solution (#3), (3) 50 µL of eight-fold PO43- solution, and (4) Tris/HCl to pH 7.4, with the use of a pH electrode (Biotrode, Metrohm Ltd., Herisau, Switzerland). Substrates were kept at 37°C on a horizontal shaker, removed from solution after 24 hrs, immediately rinsed with de-ionized water, and gently dried with dust-free air. Each experiment was repeated 5 or 3 times for samples cut perpendicular or parallel to the extrusion axis, respectively.
AFM Imaging and Raman Spectroscopy
All substrates were studied before and after the experiment by AFM (Nanoscope III, Digital Instruments, Santa Barbara, CA, USA) in tapping mode with high aspect-ratio Si-tips (r ~ 5 nm, l ~ 125 µm) (Nanosensors, Neuchatel, Switzerland) operating at approximately 300 kHz as described elsewhere (Habelitz et al., 2002). The height of the FAP crystals with respect to the surrounding glass was determined as an average from the 3 highest points along 3 lines across a FAP crystal. Bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, MO, USA) was used as a control at concentrations of 2.0 mg/mL at pH 7.4.
We used micro-Raman spectroscopy with a 20-mW He-Ne laser at a wavelength of 632.8 nm (HR 800, Jobin Ivon, Horiba Group, Tokyo, Japan) through an optical lens at 50X magnification to obtain spectra in the range from 600 to 1800 cm1.
| RESULTS |
|---|
|
|
|---|
When the FAP substrates were immersed in CaP-sol without proteins, mineral precipitated sparsely and randomly as 15- to 20-nm spheres on the surface. Furthermore, a thin layer of mineral formed on the (001)-planes of FAP crystals, which continuously increased in height until they overgrew the surrounding glass matrix by about 3 to 5 nm at 24 hrs (Fig. 2a
).
|
As a control, substrates were immersed for 24 hrs in a BSA-solution mixed with CaP-sol. In comparison with the protein-free CaP-sol, the growth of layers on FAP appeared to be reduced to less than a 3-nm increase in height when BSA was added (Fig. 2f
), but the difference was not statistically significant.
Glass-ceramic substrates that exposed predominantly (hk0)- surfaces (Fig. 3a
) were immersed in CaP-sol containing 0.4 or 1.6 mg/mL rH174. In agreement with observations on (001)- planes, amelogenin nanospheres mixed with random precipitation covered the substrate when immersed in CaP-sol with 0.4 mg/mL rH174. However, we observed only little or no formation of a layer on FAP crystals. The level of FAP remained about 25 nm below the surrounding glass (Fig. 3b
). In contrast, at high protein concentrations, the growth pattern was altered. Layers grown on (hk0)- planes were textured (Fig. 3c
), with strings of 48 nanoparticles (diameter = 3060 nm) aligned parallel to each other along the c-axis of the underlying FAP crystals. In accordance with the observation on (001)- planes, reactions of the mineralizing protein solutions were restricted to the (hk0)- planes of FAP (Figs. 2d
, 3d
). Due to occasional crystal misalignment, (hk0)- planes and (001)- planes were observed close to each other, facilitating a direct comparison between the two crystallographic orientations. The final layer height on (hk0)- planes (2040 nm) was at least 510 times smaller than that on (001)- planes (100300 nm) (Fig. 3d
).
|
|
| DISCUSSION |
|---|
|
|
|---|
When the substrates were immersed in calcium phosphate solutions, we observed that, despite the relatively low degree of saturation, mineral formation was induced. Both heterogeneous nucleation and precipitation of nanoparticles, as well as growth of the FAP crystals to levels above the glass level, were observed. We assume that the latter was a result of homogeneous nucleation of apatite on FAP. In contrast, homogeneous nucleation was not clearly identified on (hk0)- planes of FAP (Fig. 3b
). This finding can be linked to the extremely low Ca2+ concentration in the developing enamel. The low total concentration of 0.5 mM and an even lower free-Ca2+ concentration may be required to avoid homogeneous nucleation and growth perpendicular to the c-axis of apatite and thickening of the fibrous enamel crystallites.
While the addition of 0.4 mg/mL rH174 to the mineralizing solution had no significant effect on mineral precipitation and crystal growth, growth patterns were strongly altered when 1.6 mg/mL rH174 were supplemented. Layers grown on (001)- planes of FAP were, on average, about 20 times higher than those at low rH174 concentrations, indicating that the precipitated form of rH174 interacted differently with the forming mineral and accelerated crystal growth. The mechanisms for increased crystallization rates are unknown, but this study showed that the affinity of rH174 to apatite increased strongly when the protein precipitated in a supersaturated calcium phosphate solution. Under these conditions, reactions of the mineralizing solution became specific to the FAP crystals of the substrate. Only minor precipitation was observed on the surrounding glass.
The origin of fibrous enamel crystals has been attributed to the ability of amelogenin proteins to interact with specific crystal planes. Kirkham et al.(2000) showed that certain domains exist on extracted enamel crystals, which may relate to specific binding sites for amelogenin proteins, as reported by Wallwork et al.(2001). A current model (Robinson et al., 1998; Fincham et al., 1999) suggests that the bound protein blocks growth perpendicularly to the c-axis, preventing widening and early crystal fusion. Given the limitations of in vitro experiments, this study provided evidence for this mechanism, since nanoparticles of about 40 to 60 nm aligned along the c-axis of FAP, indicating specific binding sites for assembled amelogenin proteins on apatite. Thus, the assembled proteins formed short strings that may protect the crystal from lateral growth and could indeed provide the guidance required to produce a fibrous and aligned apatite crystal as observed in vivo, which is further enhanced by the amelogenin-induced accelerated growth of apatite parallel to the c-axis. However, this mechanism appears to be effective at high protein concentrations only. Future studies will require the addition of other matrix proteins, as well as proteolytic degradation of amelogenin by proteinases, to establish a more complete model of enamel formation on the molecular level and, eventually, to create artificial enamel in vitro by a biomimetic approach.
| ACKNOWLEDGMENTS |
|---|
Received February 5, 2003; Last revision May 27, 2004; Accepted June 24, 2004
| REFERENCES |
|---|
|
|
|---|
Aoba T, Fukae M, Tanabe T, Shimizu M, Moreno EC (1987). Selective adsorption of porcine-amelogenins onto hydroxyapatite and their inhibitory activity on hydroxyapatite growth in supersaturated solutions. Calcif Tissue Int 41:281289.[ISI][Medline]
Doi Y, Eanes ED, Shimokawa H, Termine JD (1984). Inhibition of seeded growth of enamel apatite crystals by amelogenin and enamelin proteins in vitro. J Dent Res 63:98105.
Fincham AG, Moradian-Oldak J, Simmer JP (1999). The structural biology of the developing dental enamel matrix. J Struct Biol 126:270299.[ISI][Medline]
Fukae M, Tanabe T, Ijiri H, Shimizu M (1980). Studies on porcine enamel proteins: a possible original enamel protein. Tsurumi Shigaku 6:8794.[Medline]
George A, Sabsay B, Simonian PA, Veis A (1993). Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization. J Biol Chem 268:1262412630.
Habelitz S, Balooch M, Marshall S, Balooch G, Marshall G (2002). In situ atomic force microscopy of partially demineralized human dentin collagen fibrils. J Struct Biol 138:227236.[ISI][Medline]
Hoche T, Moisescu C, Avramov I, Russel C, Heerdegen WD, Jager C (2001). Microstructure of SiO2-Al2O3 -CaO-P2O5 -Na2O-K2O-F glass ceramics. 2. Time dependence of apatite crystal growth. Chem Mater 13:13201325.
Hunter GK, Curtis HA, Grynpas MD, Simmer JP, Fincham AG (1999). Effects of recombinant amelogenin on hydroxyapatite formation in vitro. Calcif Tissue Int 65:226231.[ISI][Medline]
Kirkham J, Zhang J, Brookes SJ, Shore RC, Wood SR, Smith DA, et al. (2000). Evidence for charge domains on developing enamel crystal surfaces. J Dent Res 79:19431947.
Larsen J (2001). Ion products of calcium phosphate solutions. Aarhus, Denmark: Royal Dental College.
Li W, Gao C, Yan Y, DenBesten PK (2003). X-linked amelogenesis imperfecta may result from decreased formation of tyrosine rich amelogenin peptide (TRAP). Arch Oral Biol 48:177183.[ISI][Medline]
MacDougall M, Simmons D, Luan X, Nydegger J, Feng J, Gu TT (1997). Dentin phosphoprotein and dentin sialoprotein are cleavage products expressed from a single transcript coded by a gene on human chromosome 4. Dentin phosphoprotein DNA sequence determination. J Biol Chem 272:835842.
Moisescu C, Jana C, Russel C (1999a). Crystallization of rod-shaped fluoroapatite from glass melts in the system SiO2-Al2O3 -CaO-P2O5 -Na2O-K2O-F. J Non-Cryst Solids 248:169175.
Moisescu C, Jana C, Habelitz S, Carl G, Russel C (1999b). Oriented fluoroapatite glass-ceramics. J Non-Cryst Solids 248:176182.
Moradian-Oldak J (2001). Amelogenins: assembly, processing and control of crystal morphology. Matrix Biol 20:293305.[ISI][Medline]
Moradian-Oldak J (2003). Clarification of analysis of hydroxyapatite surface coverage by amelogenin nanospheres. Calcif Tissue Int 74:124125.[Medline]
Moradian-Oldak J, Tan J, Fincham AG (1998). Interaction of amelogenin with hydroxyapatite crystals: an adherence effect through amelogenin molecular self-association. Biopolymers 46:225238.[ISI][Medline]
Moradian-Oldak J, Paine ML, Lei YP, Fincham AG, Snead ML (2000). Self-assembly properties of recombinant engineered amelogenin proteins analyzed by dynamic light scattering and atomic force microscopy. J Struct Biol 131:2737.[ISI][Medline]
Penel G, Leroy G, Rey C, Bres E (1998). MicroRaman spectral study of the PO4 and CO3 vibrational modes in synthetic and biological apatites. Calcif Tissue Int 63:475481.[ISI][Medline]
Robinson C, Brookes SJ, Shore RC, Kirkham J (1998). The developing enamel matrix: nature and function. Eur J Oral Sci 106(Suppl 1):282291.
Saito T, Yamauchi M, Abiko Y, Matsuda K, Crenshaw MA (2000). In vitro apatite induction by phosphophoryn immobilized on modified collagen fibrils. J Bone Miner Res 15:16151619.[ISI][Medline]
Salih E, Huang JC, Strawich E, Gouverneur M, Glimcher MJ (1998). Enamel specific protein kinases and state of phosphorylation of purified amelogenins. Connect Tissue Res 38:225235.[Medline]
Smith CE (1998). Cellular and chemical events during enamel maturation. Crit Rev Oral Biol Med 9:128161.
Snead ML, Lau EC, Zeichner-David M, Fincham AG, Woo SL, Slavkin HC (1985). DNA sequence for cloned cDNA for murine amelogenin reveals the amino acid sequence for enamel-specific protein. Biochem Biophys Res Commun 129:812818.[ISI][Medline]
Tan J, Leung W, Moradian-Oldak J, Zeichner-David M, Fincham AG (1998). Quantitative analysis of amelogenin solubility. J Dent Res 77:13881396.
Wallwork ML, Kirkham J, Zhang J, Smith DA, Clarkson BH, Brookes SJ, et al. (2001). Binding of matrix proteins to developing enamel crystals: an atomic force microscopy study. Langmuir 17:25082513.
Wen HB, Moradian-Oldak J, Fincham AG (1999a). Modulation of apatite crystal growth on Bioglass by recombinant amelogenin. Biomaterials 20:17171725.[ISI][Medline]
Wen HB, Moradian-Oldak J, Leung W, Bringas P Jr, Fincham AG (1999b). Microstructures of an amelogenin gel matrix. J Struct Biol 126:4251.[ISI][Medline]
Wen HB, Moradian-Oldak J, Zhong JP, Greenspan DC, Fincham AG (2000). Effects of amelogenin on the transforming surface microstructures of Bioglass in a calcifying solution. J Biomed Mater Res 52:762773.[ISI][Medline]
Wen HB, Fincham AG, Moradian-Oldak J (2001). Progressive accretion of amelogenin molecules during nanospheres assembly revealed by atomic force microscopy. Matrix Biol 20:387395.[ISI][Medline]
Zheng S, Tu AT, Renugopalakrishnan V, Strawich E, Glimcher MJ (1987). A mixed beta-turn and beta-sheet structure for bovine tooth enamel amelogenin: Raman spectroscopic evidence. Biopolymers 26:18091813.[ISI][Medline]
This article has been cited by other articles:
![]() |
K. Tanimoto, T. Le, L. Zhu, J. Chen, J.D.B. Featherstone, W. Li, and P. DenBesten Effects of Fluoride on the Interactions between Amelogenin and Apatite Crystals J. Dent. Res., January 1, 2008; 87(1): 39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.C. Margolis, E. Beniash, and C.E. Fowler Role of Macromolecular Assembly of Enamel Matrix Proteins in Enamel Formation J. Dent. Res., September 1, 2006; 85(9): 775 - 793. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |